"Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic SWOT...

The company develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, diabetes and heart failure. It has developed adult stem cell technology to produce monocyte derived stem cells.

http://ift.tt/1ATUj61